A canonical structure for the ligandbinding domain of nuclear receptors

Nature Structural Biology

Volumn 3, Issue 1, 1996, Pages 87-94

  Wurtz, Jean Marie ^a   Bourguet, William ^a   Renaud, Jean Paul ^a   Vivat, Valérie ^a   Chambon, Pierre ^a   Moras, Dino ^a   Gronemeyer, Hinrich ^a  

^a PSL Research University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; GLUCOCORTICOID RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; GENETIC TRANSCRIPTION; HYDROPHOBICITY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN FOLDING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEQUENCE ALIGNMENT;

EID: 0030056997     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsb0196-87     Document Type: Article

References (27)

1. Gronemeyer, H. & Laudet, V. Nuclear Receptors. Protein Profile 2, (Academic Press, 1995), in the press.
2. Green, S. & Chambon, P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 4, 309-314 (1983).
3. Evans, R.M. The steroid and thyroid hormone receptor superfamily. Science 240, 889-895 (1988).
4. Gronemeyer, H. Transcription activation by estrogen and progesterone receptors. A Rev. Genet 25, 89-123 (1991).
5. Leid, M., P. Kastner & P. Chambon. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17, 427-433 (1992).
6. Chambon, P. The retinoid signalling pathway: molecular and genetic analysis. Semin. Cell Biol. 5, 115-125 (1994).
7. Saatcioglu, F., Claret, F.X. & Karin, M. Negative transcriptional regulation by nuclear receptors. Sem. Cancer Biol. 5, 347-359 (1994).
8. Dey, A., Minucci, S. & Ozato, K. Ligand-dependent occupancy of the retinoic acid receptor beta 2 promoter in vivo. Mol. cell. Biol. 14, 8191-8201 (1994).
9. Truss, M., Bartsch, J. & Beato, M. Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo. Proc. natn. Acad. Sci. U.S.A. 91, 11333-11337 (1994).
10. Zenke, M., Munoz, A., Sap, J., Vennström, B. & Beug, H. V-erba oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell 61, 1035-1049 (1990).
11. Danielian, P.S., White, R., Lees, J.A. & Parker, M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11, 1025-1033 (1992).
12. Barretino, D., Vivanco-Ruiz, M.d.M. & Stunnenberg, H.G. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13, 3039-3049 (1994).
13. Durand, B. et al. Activation function 2 (AF-2) of RAR and RXR: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13, 5370-5382 (1994).
14. Leng, X. et al. Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region. Mol. cell. Biol. 15, 255-263 (1995).
15. Halachmi, S. et al. Oestrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264, 1455-1458 (1994).
16. Cavaillès, V., Dauvois, S., Danielian, P.S. & Parker, M.G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. natn. Acad. Sci. U.S.A. 91, 10009-10013 (1994).
17. Cavaillès, V. et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741-3751 (1995).
18. LeDouarin, B. et al. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14, 2020-2033 (1995).
19. Lee, J.W., Ryan, F., Swaffield, J.C., Johnston, S.A., & Moore, D.A. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374, 91-94 (1995).
20. Vom Baur, E. et al. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. in the press.
21. Hörlein, A.J. et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397-403 (1995).
22. Kurokawa, R. et al. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377, 451-454 (1995).
23. Chen, J.D. & Evans, R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454-457 (1995).
24. Gronemeyer, H. & Moras, D. How to finger DNA. Nature 375, 190-191 (1995).
25. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. & Moras, D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXRa. Nature 375, 377-382 (1995).
26. Renaud, J.P. et al. D Crystal structure of the RARg ligand-binding domain bound to all-trans retinoic acid. Nature in the press.
27. Laudet, V., Hanni, C., Coll, J., Catzeflis, F. & Stehelin, D. Evolution of the nuclear receptor gene superfamily. EMBO J. 11, 1003-1013 (1992).